| Literature DB >> 34795804 |
Shuo Xu1, Zhijie Yan1,2, Yongquan Pan1, Qing Yang1, Zhilan Liu3, Jiajia Gao4, Yanhui Yang5, Yufen Wu6, Yanan Zhang7, Jianhui Wang8, Ren Zhuang9, Chong Li1,10, Yongli Zhang1,11, Jie Jia1,12,13.
Abstract
METHODS: Patients with stroke were compared and correlated from overall and three periods (1-3 months, 4-6 months, and >6 months). Fugl-Meyer assessment for the upper extremity (FMA-UE) and action research and arm test (ARAT) were used to compare the UE motor status between patients with PSA and without PSA through a cross-sectional study among 435 patients. Then, the correlations between the evaluation scale scores of UE motor status and language function of patients with PSA were analyzed in various dimensions, and the language subfunction most closely related to UE motor function was analyzed by multiple linear regression analysis.Entities:
Mesh:
Year: 2021 PMID: 34795804 PMCID: PMC8595012 DOI: 10.1155/2021/9417173
Source DB: PubMed Journal: Behav Neurol ISSN: 0953-4180 Impact factor: 3.342
Figure 1Flow chart of the study sample and procedures of the comparison and analyses. WAB-AQ indicates the Western Aphasia Battery-Aphasia Quotient; FMA-UE indicates the Fugl-Meyer assessment for the upper extremity; ARAT indicates the action research and action test.
(a) Comparisons of demographic data between the PSA group and the non-PSA group
| PSA group ( | Non-PSA group ( |
| |
|---|---|---|---|
| Female, | 82 (38.3) | 71 (32.1) | 0.176b |
| Age, mean (SD) (y) | 61.1 ± 11.9 | 60.1 ± 10.4 | 0.340a |
| Education, mean (SD) (y) | 10.32 ± 3.7 | 10.91 ± 5.4 | 0.184a |
| Duration poststroke, median (IQR) (week) | 16 (6-35) | 14 (7-32) | 0.316c |
| Type of injury, | 0.586b | ||
| Ischemia | 180 (84.1) | 190 (86.0) | |
| Hemorrhage | 34 (15.9) | 31 (14.0) | |
| Affected limb, | 0.297b | ||
| Right | 167 (78.0) | 163 (73.8) | |
| Left | 47 (22.0) | 58 (26.2) | |
(b) Comparisons of clinical variables between the PSA group and the non-PSA group
| PSA group ( | Non-PSA group ( | Mean difference (95% CI) |
| |
|---|---|---|---|---|
| Motor evaluation, median (IQR) | ||||
| FMA-UE | 20 (7-40) | 35 (23-52) | 14 (10, 18) | <0.001c |
| ARAT | 5.5 (0-30) | 21 (11-45) | 11 (8, 13) | <0.001c |
| Language evaluation, median (IQR) | ||||
| BDAE | 1.57 ± 1.18 | 5 | -3.43 (-3.6, -3.3) | <0.001d |
| WAB-AQ | 44.6 (18.1-70.6) | |||
| Spontaneous speech | 7.0 (2.0-13.0) | |||
| Comprehension | 126.0 (60.0-175.0) | |||
| Repetition | 50.0 (9.8-80.0) | |||
| Naming | 27.0 (0.8-67.3) | |||
aTwo independent sample t-test. bχ2 test. cWilcoxon's rank sum test. dSingle sample t-test. Abbreviations: SD indicates standard error of the mean; IQR indicates interquartile range; CI indicates confidence interval; FMA-UE indicates the Fugl-Meyer assessment of the upper extremity; ARAT indicates the action research and action test; BDAE indicates the Boston Diagnostic Aphasia Examination; WAB-AQ indicates the Western Aphasia Battery-Aphasia Quotient.
Figure 2Clinical measurement of the FMA-UE and ARAT scores. (a) Comparison of the FMA-UE and ARAT total scores between the non-PSA and PSA groups. (b–d) Comparisons of the FMA-UE and ARAT total scores between the non-PSA and PSA groups in 1-3 months, 4-6 months, and >6 months. Significant differences were observed in both groups. p < 0.001. Abbreviation: non-PSA indicates patients without poststroke aphasia; PSA indicates patients with poststroke aphasia; FMA-UE indicates the Fugl-Meyer assessment for the upper extremity; ARAT indicates the action research and action test.
Pearson's correlation between four parts of WAB-AQ and FMA-UE and ARAT scores.
|
| |||||
|---|---|---|---|---|---|
| Language motor | WAB-AQ | Spontaneous speech | Comprehension | Repetition | Naming |
| FMA-UE† | 0.70 | 0.72 | 0.53 | 0.60 | 0.64 |
| ARAT† | 0.62 | 0.66 | 0.45 | 0.52 | 0.57 |
| FMA-UE∗ | 0.59 | 0.60 | 0.46 | 0.52 | 0.46 |
| ARAT∗ | 0.54 | 0.60 | 0.42 | 0.42 | 0.45 |
| FMA-UE∗∗ | 0.76 | 0.76 | 0.57 | 0.65 | 0.72 |
| ARAT∗∗ | 0.68 | 0.68 | 0.48 | 0.57 | 0.67 |
| FMA-UE∗∗∗ | 0.71 | 0.76 | 0.52 | 0.62 | 0.67 |
| ARAT∗∗∗ | 0.65 | 0.70 | 0.46 | 0.58 | 0.61 |
†Correlation analyses of the overall time period. ∗Correlation analyses of 1-3 months. ∗∗Correlation analyses of 4-6 months. ∗∗∗Correlation analyses of >6 months. FMA-UE indicates the Fugl-Meyer assessment for the upper extremity; ARAT indicates the action research and action test; WAB-AQ indicates the Western Aphasia Battery-Aphasia Quotient. p < 0.001. The correlation coefficients are corrected for age, education, and duration poststroke.
Figure 3Correlation and regression in independent evaluation scores. (a, b) The association of AQ with FMA-UE and ARAT is shown. (c, d) The correlation of spontaneous speech and FMA-UE and ARAT is shown using linear regression equation. p < 0.001. FMA-UE indicates the Fugl-Meyer Assessment of the Upper Extremity; ARAT indicates the action research and action test; AQ indicates the Western Aphasia Battery-Aphasia Quotient.
Figure 4Correlations of independent evaluation scores in different times from stroke onset. (a, b) The association of AQ with FMA-UE and ARAT in 1-3 months is shown. (c, d) The association of AQ with FMA-UE and ARAT in 4-6 months is shown. (e, f) The correlation of AQ with FMA-UE and ARAT in >6 months. p < 0.001. FMA-UE indicates the Fugl-Meyer assessment of the upper extremity; ARAT indicates the action research and action test; AQ indicates the Western Aphasia Battery-Aphasia Quotient.
Figure 5The association between UE motor status and language function after PSA. Schematic diagram shows partial correlations in an eight-way analysis of FMA-UE; ARAT; and spontaneous speech, comprehension, repetition, and naming. The degree of the arrow thickness between two modules is proportional to the correlation coefficient. FMA-UE indicates the Fugl-Meyer assessment for the upper extremity; ARAT indicates the action research and action test.